Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Nov 5, 2021

Accession no.
0001209191-21-063225
Filed
Nov 5, 2021
Trade date
Oct 1-29, 2021
Filing delay
35 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $856.95. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2021Common StockPPurchaseAcquired+15$2.69+$40.3513,688Direct
Oct 4, 2021Common StockPPurchaseAcquired+15$2.87+$43.0513,703Direct
Oct 5, 2021Common StockPPurchaseAcquired+15$2.82+$42.313,718Direct
Oct 6, 2021Common StockPPurchaseAcquired+15$2.76+$41.413,733Direct
Oct 7, 2021Common StockPPurchaseAcquired+15$2.76+$41.413,748Direct
Oct 8, 2021Common StockPPurchaseAcquired+15$2.84+$42.613,763Direct
Oct 11, 2021Common StockPPurchaseAcquired+15$2.73+$40.9513,778Direct
Oct 12, 2021Common StockPPurchaseAcquired+15$2.71+$40.6513,793Direct
Oct 13, 2021Common StockPPurchaseAcquired+15$2.71+$40.6513,808Direct
Oct 14, 2021Common StockPPurchaseAcquired+15$2.81+$42.1513,823Direct
Oct 15, 2021Common StockPPurchaseAcquired+15$2.76+$41.413,838Direct
Oct 18, 2021Common StockPPurchaseAcquired+15$2.75+$41.2513,853Direct
Oct 19, 2021Common StockPPurchaseAcquired+15$2.76+$41.413,868Direct
Oct 20, 2021Common StockPPurchaseAcquired+15$2.63+$39.4513,883Direct
Oct 21, 2021Common StockPPurchaseAcquired+15$2.65+$39.7513,898Direct
Oct 22, 2021Common StockPPurchaseAcquired+15$2.66+$39.913,913Direct
Oct 25, 2021Common StockPPurchaseAcquired+15$2.64+$39.613,928Direct
Oct 26, 2021Common StockPPurchaseAcquired+15$2.64+$39.613,943Direct
Oct 27, 2021Common StockPPurchaseAcquired+15$2.61+$39.1513,958Direct
Oct 28, 2021Common StockPPurchaseAcquired+15$2.61+$39.1513,975Direct
Oct 29, 2021Common StockPPurchaseAcquired+15$2.72+$40.813,988Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)